133 results
8-K
EX-99.1
SAVA
Cassava Sciences Inc
3 Aug 22
Cassava Sciences Reports Second Quarter Financial Results for 2022, Mid-year Corporate Update and Interim Analysis of Open-label Study
9:25am
subscale (ADAS-Cog) was originally developed by the research community to measure cognitive impairment in patients with Alzheimer’s disease. ADAS-Cog
8-K
EX-99.1
o12d4
28 Feb 22
Cassava Sciences Reports Full-year 2021 Financial Results and Operating Updates
12:00am
8-K
EX-10.1
of89 pqnc
11 Mar 21
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
4:59pm
S-3ASR
EX-4.5
eq6ccuspbnsz
10 Feb 21
Automatic shelf registration
6:04am
S-3ASR
EX-4.6
3pra5a5nuhno dby5o
10 Feb 21
Automatic shelf registration
6:04am
8-K
EX-99.1
t9lbzb6s908
29 Oct 19
Cassava Sciences Announces Recent Clinical Highlights and Third Quarter 2019 Financial Results
8:29am